Jung YH - Search Results

1

Radiotherapy versus Surgery in Early-Stage HPV-Positive Oropharyngeal Cancer.

Kim DY, Wu HG, Kim JH, Lee JH, Ahn SH, Chung EJ, Eom KY, Jung YH, Jeong WJ, Kwon TK, Kim S, Wee CW. Kim DY, et al. Among authors: jung yh. Cancer Res Treat. 2022 Apr;54(2):406-416. doi: 10.4143/crt.2021.441. Epub 2021 Jun 23. Cancer Res Treat. 2022. PMID: 34176249 Free PMC article.

2

Role of surgical salvage for regional recurrence in laryngeal cancer.

Jeong WJ, Jung YH, Kwon SK, Hah JH, Kwon TK, Sung MW, Kim KH. Jeong WJ, et al. Among authors: jung yh. Laryngoscope. 2007 Jan;117(1):74-7. doi: 10.1097/01.mlg.0000240184.75588.dc. Laryngoscope. 2007. PMID: 17202934

3

Presence of HPV type 6 in dysplasia and carcinoma arising from recurrent respiratory papillomatosis.

Jeong WJ, Park SW, Shin M, Lee YJ, Jeon YK, Jung YH, Hah JH, Kwon TK, Song YS, Kim KH, Sung MW. Jeong WJ, et al. Among authors: jung yh. Head Neck. 2009 Aug;31(8):1095-101. doi: 10.1002/hed.20998. Head Neck. 2009. PMID: 19072996

4

Clinical manifestations of recurrent parotid pleomorphic adenoma.

Suh MW, Hah JH, Kwon SK, Jung YH, Kwon TK, Kim KH, Sung MW. Suh MW, et al. Among authors: jung yh. Clin Exp Otorhinolaryngol. 2009 Dec;2(4):193-7. doi: 10.3342/ceo.2009.2.4.193. Epub 2009 Dec 31. Clin Exp Otorhinolaryngol. 2009. PMID: 20072694 Free PMC article.

5

Efficacy of current regular follow-up policy after treatment for head and neck cancer: Need for individualized and obligatory follow-up strategy.

Jung YH, Song CM, Park JH, Kim H, Cha W, Hah JH, Kwon TK, Kim KH, Sung MW. Jung YH, et al. Head Neck. 2014 May;36(5):715-21. doi: 10.1002/hed.23364. Epub 2013 Jul 30. Head Neck. 2014. PMID: 23616261

6

Expression of hypoxic signaling markers in head and neck squamous cell carcinoma and its clinical significance.

Choi HG, Kim JS, Kim KH, Kim KH, Sung MW, Choe JY, Kim JE, Jung YH. Choi HG, et al. Among authors: jung yh. Eur Arch Otorhinolaryngol. 2015 Jan;272(1):219-28. doi: 10.1007/s00405-014-2954-1. Epub 2014 Mar 14. Eur Arch Otorhinolaryngol. 2015. PMID: 24627073

7

Antitumor effect of CXCR4 antagonist AMD3100 on the tumorigenic cell line of BHP10-3 papillary thyroid cancer cells.

Jung YH, Lee DY, Cha W, Kim BH, Sung MW, Kim KH, Ahn SH. Jung YH, et al. Head Neck. 2016 Oct;38(10):1479-86. doi: 10.1002/hed.24461. Epub 2016 Apr 7. Head Neck. 2016. PMID: 27061747

8

CD271 Confers an Invasive and Metastatic Phenotype of Head and Neck Squamous Cell Carcinoma through the Upregulation of Slug.

Chung MK, Jung YH, Lee JK, Cho SY, Murillo-Sauca O, Uppaluri R, Shin JH, Sunwoo JB. Chung MK, et al. Among authors: jung yh. Clin Cancer Res. 2018 Feb 1;24(3):674-683. doi: 10.1158/1078-0432.CCR-17-0866. Epub 2017 Dec 5. Clin Cancer Res. 2018. PMID: 29208672 Free PMC article.

9

Prognostic value of FDG PET/CT during radiotherapy in head and neck cancer patients.

Kim S, Oh S, Kim JS, Kim YK, Kim KH, Oh DH, Lee DH, Jeong WJ, Jung YH. Kim S, et al. Among authors: jung yh. Radiat Oncol J. 2018 Jun;36(2):95-102. doi: 10.3857/roj.2017.00577. Epub 2018 Jun 29. Radiat Oncol J. 2018. PMID: 29983029 Free PMC article.

10

Long-term oncological and functional outcomes of induction chemotherapy followed by (chemo)radiotherapy vs definitive chemoradiotherapy vs surgery-based therapy in locally advanced stage III/IV hypopharyngeal cancer: Multicenter review of 266 cases.

Chung EJ, Jeong WJ, Jung YH, Kwon SK, Kwon TK, Ahn SH, Sung MW, Keam B, Heo DS, Kim JH, Wu HG, Lee KW, Eom KY, Rho YS. Chung EJ, et al. Among authors: jung yh. Oral Oncol. 2019 Feb;89:84-94. doi: 10.1016/j.oraloncology.2018.12.015. Epub 2018 Dec 27. Oral Oncol. 2019. PMID: 30732965

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,027 results

Search Page